BerriganWABailowitzZParkAReddyALiuRLansdownD.A greater platelet dose may yield better clinical outcomes for platelet-rich plasma in the treatment of knee osteoarthritis: a systematic review. Arthroscopy. 2025;41(3):809-817.e2.
2.
BoffaADe MarzianiLAndrioloL. et al. Influence of platelet concentration on the clinical outcome of platelet-rich plasma injections in knee osteoarthritis. Am J Sports Med. 2024;52(13):3223-3231. doi:10.1177/03635465241283463
3.
CaoYLuoJHanS. et al. A model-based quantitative analysis of efficacy and associated factors of platelet rich plasma treatment for osteoarthritis. Int J Surg. 2023;109(6):1742-1752.
4.
Del AmoCPerez-ValleAAtilanoLAndiaI. Unraveling the signaling secretome of platelet-rich plasma: towards a better understanding of its therapeutic potential in knee osteoarthritis. J Clin Med. 2022;11(3):473. doi:10.3390/jcm11030473
5.
MurrayIRGeeslinAGGoudieEBPetriglianoFALaPradeRF.Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells. J Bone Joint Surg Am. 2017;99(10):809-819.
6.
SánchezMDelgadoD.Regarding “A greater dose may yield better clinical outcomes for platelet-rich plasma in the treatment of knee osteoarthritis.”Arthroscopy. 2025;41(4):866-867.
